Meta‐analyses of clinical trials refute these mechanistic claims in human data, suggesting that GLP‐1 RAs do not increase the risk of thyroid, pancreatic, breast, or any other cancer.39, 40, 41. This evidence concerns the gene GLP1R and cancer.